Unknown Manufacturer
Alefacept is a recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis.
Alefacept is a recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis.
Inhibits T-lymphocyte activation and production by binding to the CD2 lymphocyte antigen.
As an immunosuppressive drug, Alefacept can be used for treatment of moderate to severe chronic plaque psoriasis
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
